Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome

Thromb Haemost. 2014 Aug;112(2):419-20. doi: 10.1160/TH14-02-0104. Epub 2014 Apr 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Aged, 80 and over
  • Anticoagulants / administration & dosage*
  • Anticoagulants / blood
  • Anticoagulants / pharmacokinetics
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / administration & dosage*
  • Benzimidazoles / blood
  • Benzimidazoles / pharmacokinetics
  • Biological Availability
  • Blood Coagulation / drug effects*
  • Dabigatran
  • Drug Monitoring
  • Drug Substitution
  • Factor Xa Inhibitors / administration & dosage
  • Female
  • Humans
  • Infarction, Middle Cerebral Artery / diagnosis
  • Infarction, Middle Cerebral Artery / etiology*
  • Infarction, Middle Cerebral Artery / prevention & control
  • Intestinal Absorption
  • Morpholines / administration & dosage
  • Predictive Value of Tests
  • Pyridines / administration & dosage*
  • Pyridines / blood
  • Pyridines / pharmacokinetics
  • Risk Factors
  • Rivaroxaban
  • Short Bowel Syndrome / complications*
  • Short Bowel Syndrome / metabolism
  • Thiophenes / administration & dosage
  • Treatment Outcome

Substances

  • Anticoagulants
  • Benzimidazoles
  • Factor Xa Inhibitors
  • Morpholines
  • Pyridines
  • Thiophenes
  • Rivaroxaban
  • Dabigatran